Associations between variants in the ABCB1 (MDR1) gene and corticosteroid dependence in children with Crohn's disease

Inflammatory Bowel Diseases

Volumn 17, Issue 11, 2011, Pages 2308-2317

  Krupoves, Alfreda ^a,b   MacK, David ^c   Seidman, Ernest ^d   Deslandres, Colette ^a   Amre, Devendra ^a,b  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

ABCB1; Crohn's disease; gene drug response; pediatric; pharmacogenetics; steroids in IBD

Indexed keywords

CORTICOSTEROID; MULTIDRUG RESISTANCE PROTEIN 1;

ADOLESCENT; ARTICLE; CANADA; CHILD; CHILDHOOD DISEASE; CORTICOSTEROID DEPENDENCE; CORTICOSTEROID THERAPY; CROHN DISEASE; DNA EXTRACTION; DRUG DEPENDENCE; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; BUDESONIDE; CHILD; COHORT STUDIES; CROHN DISEASE; DNA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUCOCORTICOIDS; HAPLOTYPES; HUMANS; MALE; P-GLYCOPROTEIN; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PREDNISONE; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 80054730001     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21608     Document Type: Article

References (57)

1. Barnes PJ,. Corticosteroid resistance in airway disease. Proc Am Thorac Soc. 2004; 1: 264-268.
2. Carmichael J, Paterson IC, Diaz P, et al. Corticosteroid resistance in chronic asthma. Br Med J (Clin Res Ed). 1981; 282: 1419-1422. (Pubitemid 11096240)
3. Chikanza IC, Kozaci DL,. Corticosteroid resistance in rheumatoid arthritis: molecular and cellular perspectives. Rheumatology (Oxford). 2004; 43: 1337-1345. (Pubitemid 39480919)
4. Munkholm P, Langholz E, Davidsen M, et al. Frequency of glucocorticoid resistance and dependency in Crohn's disease. Gut. 1994; 35: 360-362.
5. Bernstein CN, Blanchard JF, Metge C, et al. The association between corticosteroid use and development of fractures among IBD patients in a population-based database. Am J Gastroenterol. 2003; 98: 1797-1801. (Pubitemid 36959161)
6. Boot AM, Bouquet J, Krenning EP, et al. Bone mineral density and nutritional status in children with chronic inflammatory bowel disease. Gut. 1998; 42: 188-194. (Pubitemid 28214002)
7. Lukert BP, Raisz LG,. Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med. 1990; 112: 352-364. (Pubitemid 20083611)
8. Su CG, Judge TA, Lichtenstein GR,. Extraintestinal manifestations of inflammatory bowel disease. Gastroenterol Clin North Am. 2002; 31: 307-327. (Pubitemid 34733048)
9. Tripathi RC, Kirschner BS, Kipp M, et al. Corticosteroid treatment for inflammatory bowel disease in pediatric patients increases intraocular pressure. Gastroenterology. 1992; 102: 1957-1961.
10. Tripathi RC, Kipp MA, Tripathi BJ, et al. Ocular toxicity of prednisone in pediatric patients with inflammatory bowel disease. Lens Eye Toxic Res. 1992; 9: 469-482. (Pubitemid 23111717)
11. Krupoves A, Mack DR, Seidman EG, et al. Immediate and long-term outcomes of corticosteroid therapy in pediatric crohn's disease patients. Inflamm Bowel Dis. 2010 [Epub ahead of print].
12. Markowitz J, Grancher K, Kohn N, et al. A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease. Gastroenterology. 2000; 119: 895-902.
13. Markowitz J, Hyams J, Mack D, et al. Corticosteroid therapy in the age of infliximab: acute and 1-year outcomes in newly diagnosed children with Crohn's disease. Clin Gastroenterol Hepatol. 2006; 4: 1124-1129. (Pubitemid 44311642)
14. Krupoves A, Mack D, Deslandres C, et al. Variation in the glucocorticoid receptor gene (NR3C1) may be associated with corticosteroid dependency in children with Crohn's disease. Pharmacogenet Genomics. 2010 (Submitted).
15. Urcelay E, Mendoza JL, Martin MC, et al. MDR1 gene: susceptibility in Spanish Crohn's disease and ulcerative colitis patients. Inflamm Bowel Dis. 2006; 12: 33-37. (Pubitemid 43032449)
16. Potocnik U, Ferkolj I, Glavac D, et al. Polymorphisms in multidrug resistance 1 (MDR1) gene are associated with refractory Crohn disease and ulcerative colitis. Genes Immun. 2004; 5: 530-539. (Pubitemid 39529969)
17. Brant SR, Panhuysen CI, Nicolae D, et al. MDR1 Ala893 polymorphism is associated with inflammatory bowel disease. Am J Hum Genet. 2003; 73: 1282-1292. (Pubitemid 38037422)
18. Ardizzone S, Maconi G, Bianchi V, et al. Multidrug resistance 1 gene polymorphism and susceptibility to inflammatory bowel disease. Inflamm Bowel Dis. 2007; 13: 516-523. (Pubitemid 46799634)
19. Croucher PJ, Mascheretti S, Foelsch UR, et al. Lack of association between the C3435T MDR1 gene polymorphism and inflammatory bowel disease in two independent Northern European populations. Gastroenterology. 2003; 125: 1919-1920.
20. De Iudicibus S, Stocco G, Martelossi S, et al. Association of BclI polymorphism of the glucocorticoid receptor gene locus with response to glucocorticoids in inflammatory bowel disease. Gut. 2007; 56: 1319-131a.
21. Ho GT, Nimmo ER, Tenesa A, et al. Allelic variations of the multidrug resistance gene determine susceptibility and disease behavior in ulcerative colitis. Gastroenterology. 2005; 128: 288-296. (Pubitemid 40431082)
22. Ho GT, Soranzo N, Nimmo ER, et al. ABCB1/MDR1 gene determines susceptibility and phenotype in ulcerative colitis: discrimination of critical variants using a gene-wide haplotype tagging approach. Hum Mol Genet. 2006; 15: 797-805. (Pubitemid 43264704)
23. Oostenbrug LE, Dijkstra G, Nolte IM, et al. Absence of association between the multidrug resistance (MDR1) gene and inflammatory bowel disease. Scand J Gastroenterol. 2006; 41: 1174-1182. (Pubitemid 44451680)
24. Palmieri O, Latiano A, Valvano R, et al. Multidrug resistance 1 gene polymorphisms are not associated with inflammatory bowel disease and response to therapy in Italian patients. Aliment Pharmacol Ther. 2005; 22: 1129-1138. (Pubitemid 41779521)
25. Schwab M, Schaeffeler E, Marx C, et al. Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis. Gastroenterology. 2003; 124: 26-33. (Pubitemid 36055335)
26. Krupoves A, Seidman EG, Mack D, et al. Associations between ABCB1/MDR1 gene polymorphisms and Crohn's disease: a gene-wide study in a pediatric population. Inflamm Bowel Dis. 2009; 15: 900-908.
27. Imielinski M, Baldassano RN, Griffiths A, et al. Common variants at five new loci associated with early-onset inflammatory bowel disease. Nat Genet. 2009; 41: 1335-1340.
28. Duerr RH, Taylor KD, Brant SR, et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science. 2006; 314: 1461-1463. (Pubitemid 44871953)
29. Barrett JC, Hansoul S, Nicolae DL, et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet. 2008; 40: 955-962.
30. Rioux JD, Xavier RJ, Taylor KD, et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet. 2007; 39: 596-604. (Pubitemid 46676115)
31. Juyal G, Midha V, Amre D, et al. Associations between common variants in the MDR1 (ABCB1) gene and ulcerative colitis among North Indians. Pharmacogenet Genomics. 2009; 19: 77-85.
32. Sands BE,. From symptom to diagnosis: clinical distinctions among various forms of intestinal inflammation. Gastroenterology. 2004; 126: 1518-1532. (Pubitemid 38649870)
33. Lennard-Jones JE,. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl. 1989; 170: 2-6. (Pubitemid 20015811)
34. Ho GT, Chiam P, Drummond H, et al. The efficacy of corticosteroid therapy in inflammatory bowel disease: analysis of a 5-year UK inception cohort. Aliment Pharmacol Ther. 2006; 24: 319-330. (Pubitemid 43972900)
35. Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006; 55: 749-753. (Pubitemid 43764536)
36. Carlson CS, Eberle MA, Rieder MJ, et al. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet. 2004; 74: 106-120. (Pubitemid 38085242)
37. Barrett JC, Fry B, Maller J, et al. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005; 21: 263-265. (Pubitemid 40202029)
38. Li Y, Ding J, Abecasis GR,. Mach 1.0: rapid haplotype reconstruction and missing genotype inference. Am J Hum Genet. 2006; S79: 2290.
39. Ueda K, Okamura N, Hirai M, et al. Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone. J Biol Chem. 1992; 267: 24248-24252.
40. Mizutani T, Masuda M, Nakai E, et al. Genuine functions of P-glycoprotein (ABCB1). Curr Drug Metab. 2008; 9: 167-174. (Pubitemid 351461005)
41. Illmer T, Schuler US, Thiede C, et al. MDR1 gene polymorphisms affect therapy outcome in acute myeloid leukemia patients. Cancer Res. 2002; 62: 4955-4962. (Pubitemid 34984419)
42. Pawlik A, Wrzesniewska J, Fiedorowicz-Fabrycy I, et al. The MDR1 3435 polymorphism in patients with rheumatoid arthritis. Int J Clin Pharmacol Ther. 2004; 42: 496-503. (Pubitemid 39255621)
43. Thiebaut F, Tsuruo T, Hamada H, et al. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci U S A. 1987; 84: 7735-7738.
44. Tanigawara Y,. Role of P-glycoprotein in drug disposition. Ther Drug Monit. 2000; 22: 137-140. (Pubitemid 30083115)
45. Fojo AT, Ueda K, Slamon DJ, et al. Expression of a multidrug-resistance gene in human tumors and tissues. Proc Natl Acad Sci U S A. 1987; 84: 265-269. (Pubitemid 17013615)
46. Farrell RJ, Murphy A, Long A, et al. High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy. Gastroenterology. 2000; 118: 279-288. (Pubitemid 30067501)
47. Kroetz DL, Pauli-Magnus C, Hodges LM, et al. Sequence diversity and haplotype structure in the human ABCB1 (MDR1, multidrug resistance transporter) gene. Pharmacogenetics. 2003; 13: 481-494. (Pubitemid 37034590)
48. Fellay J, Marzolini C, Meaden ER, et al. Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study. Lancet. 2002; 359: 30-36. (Pubitemid 34119193)
49. Hoffmeyer S, Burk O, von RO, et al. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci U S A. 2000; 97: 3473-3478. (Pubitemid 30183327)
50. Kim RB, Leake BF, Choo EF, et al. Identification of functionally variant MDR1 alleles among European Americans and African Americans. Clin Pharmacol Ther. 2001; 70: 189-199. (Pubitemid 32777772)
51. Nakamura T, Sakaeda T, Horinouchi M, et al. Effect of the mutation (C3435T) at exon 26 of the MDR1 gene on expression level of MDR1 messenger ribonucleic acid in duodenal enterocytes of healthy Japanese subjects. Clin Pharmacol Ther. 2002; 71: 297-303. (Pubitemid 34311459)
52. Sakaeda T, Nakamura T, Horinouchi M, et al. MDR1 genotype-related pharmacokinetics of digoxin after single oral administration in healthy Japanese subjects. Pharm Res. 2001; 18: 1400-1404. (Pubitemid 32977244)
53. Levran O, O'Hara K, Peles E, et al. ABCB1 (MDR1) genetic variants are associated with methadone doses required for effective treatment of heroin dependence. Hum Mol Genet. 2008; 17: 2219-2227. (Pubitemid 351916578)
54. Nakamura T, Okamura N, Yagi M, et al. Effects of ABCB1 3435C>T genotype on serum levels of cortisol and aldosterone in women with normal menstrual cycles. Genet Mol Res. 2009; 8: 397-403.
55. Kwan P, Wong V, Ng PW, et al. Gene-wide tagging study of association between ABCB1 polymorphisms and multidrug resistance in epilepsy in Han Chinese. Pharmacogenomics. 2009; 10: 723-732.
56. Uhr M, Tontsch A, Namendorf C, et al. Polymorphisms in the drug transporter gene ABCB1 predict antidepressant treatment response in depression. Neuron. 2008; 57: 203-209.
57. Sarginson JE, Lazzeroni LC, Ryan HS, et al. ABCB1 (MDR1) polymorphisms and antidepressant response in geriatric depression. Pharmacogenet Genomics. 2010; 20: 467-475.